Search results for "Arterial hypertension"

showing 10 items of 69 documents

Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults

2017

Background and Aims In experimental investigations conducted in rats, raising serum uric acid (SUA) levels resulted in the stimulation of intrarenal renin expression. Studies in humans exploring the association of SUA with plasma renin activity (PRA) yielded conflicting results. Moreover, little is known about the relationship of SUA with plasma aldosterone concentration (PAC). The study aimed to assess the relationship between SUA levels, PRA, and PAC and the influence of age, gender, body mass index (BMI), and hyperuricemia on these relationships in subjects with essential hypertension (EH). Methods and Results We enrolled 372 hypertensive patients (mean age 45 ± 12 years, men 67%) with u…

MaleSettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismMedicine (miscellaneous)030204 cardiovascular system & hematologyEssential hypertensionKidneyPlasma renin activityRenin-Angiotensin Systemchemistry.chemical_compound0302 clinical medicineRisk FactorsReninNutrition and Dietetic030212 general & internal medicineHyperuricemiaAldosteroneAdiposityNutrition and DieteticsAldosteroneAge FactorsMiddle AgedHypertensionBlood pressureFemaleCardiology and Cardiovascular MedicineAdultArterial hypertensionmedicine.medical_specialtyRenal functionHyperuricemiaEssential hypertension03 medical and health sciencesSex FactorsPlasma renin activityPlasma aldosteroneInternal medicinemedicineHumansSettore MED/14 - NefrologiaCreatinineChi-Square Distributionbusiness.industrymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCross-Sectional StudieschemistryMultivariate AnalysisLinear ModelsUric acidbusinessBody mass indexUric acidBiomarkers
researchProduct

EFFECTS OF ALLOPURINOL ON RENAL FUNCTION DECLINE IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASES

2014

Aim: To evaluate retrospectively the effects of allopurinol treatment on renal function decline in non-gouty hypertensive patients with moderate-to-severe CKD. Methods: We selected 22 patients treated with allopurinol (A) (100–300 mg/die) that were compared with 44 subjects not treated with this drug (B), matched with A for estimated glomerular filtration rate (eGFR), age, gender and blood pressure values. Results: After a mean follow-up period of 16 months no significant difference was observed between the two groups regarding eGFR decline (A: -6.8 ± 11.6 ml/min/1.73 m2; B: -4.2 ± 9.3 ml/min/1.73 m2). Furthermore, the percentage of subjects with a value of eGFR reduction above the median w…

AlloprurinolAllopurinolkidney diseaserenal functionCKDUric acid; Alloprurinol; renal function; kidney diseases; arterial hypertension.Uric acidarterial hypertension.
researchProduct

Recommendations for the management of patients with obstructive sleep apnoea and hypertension.

2013

This article is aimed at addressing the current state-of-the-art in epidemiology, pathophysiology, diagnostic procedures and treatment options for appropriate management of obstructive sleep apnoea (OSA) in cardiovascular (in particular hypertensive) patients, as well as for the management of cardiovascular diseases (in particular arterial hypertension) in OSA patients. The present document is the result of work performed by a panel of experts participating in the European Union COST (Cooperation in Scientific and Technological research) Action B26 on OSA, with the endorsement of the European Respiratory Society and the European Society of Hypertension. In particular, these recommendations …

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtySleep apnoea COSTMEDLINEArterial hypertension continuous positive airway pressure treatment guidelines hypertension treatment obstructive sleep apnoeaCardiologyMyocardial IschemiaBlood PressureSettore MED/10 - Malattie Dell'Apparato Respiratoriota3111Renin-Angiotensin SystemRisk FactorsEpidemiologymedicinemedia_common.cataloged_instanceHumansIn patientObesityEuropean unionIntensive care medicineStrokeLife StyleSocieties Medicalmedia_commonAgedta3126InflammationSleep Apnea Obstructivebusiness.industryRespirationSleep apneaMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREMiddle Agedmedicine.diseaseObesityEuropeStrokeBlood pressureHypertensionFemaleEndothelium VascularbusinessThe European respiratory journal
researchProduct

RELATIONSHIP BETWEEN OBESITY AND LEFT VENTRICULAR MASS IN CAUCASIAN HYPERTENSIVE SUBJECTS. DOES SEX MATTER?

2015

Objective The excess of adiposity affects the heart through haemodynamic and non haemodynamic mechanisms leading to left ventricular hypertrophy (LVH) and ultimately to heart failure. It has been been previously observed, in a large study performed in American Indians, that the impact of obesity on left ventricular mass (LVM) is greater in women than men, while the results of other investigations carried out in other ethnic groups have yielded conflicting results .The aim of our study was to evaluate the potential influence of gender on the relationships between obesity and LVM in Caucasian patients with essential hypertension (EHs) . Design and method We enrolled 724 subjects with EH (mean…

LEFT VENTRICULAR MASSOBESITYARTERIAL HYPERTENSIONLEFT VENTRICULAR HYPERTTOPHY
researchProduct

Mild obstructive sleep apnea increases hypertension risk, challenging traditional severity classification

2020

STUDY OBJECTIVES: The association of mild obstructive sleep apnea (OSA) with important clinical outcomes remains unclear. We aimed to investigate the association between mild OSA and systemic arterial hypertension (SAH) in the European Sleep Apnea Database cohort. METHODS: In a multicenter sample of 4,732 participants, we analyzed the risk of mild OSA (subclassified into 2 groups: mild(AHI 5-<11/h) (apnea-hypopnea index [AHI], 5 to <11 events/h) and mild(AHI 11-<15/h) (AHI, ≥11 to <15 events/h) compared with nonapneic snorers for prevalent SAH after adjustment for relevant confounding factors including sex, age, smoking, obesity, daytime sleepiness, dyslipidemia, chronic obstructive pulmona…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEuropean Sleep Apnea Database Mild obstructive sleep apnea Systemic arterial hypertensionPolysomnographyDisorders of Excessive SomnolenceSettore MED/10 - Malattie Dell'Apparato RespiratorioHypertension risk03 medical and health sciences0302 clinical medicinestomatognathic systemRisk FactorsInternal medicinesystemic arterial hypertensionmedicineHumansEuropean Sleep Apnea DatabaseSleep Apnea ObstructiveSystemic arterial hypertensionbusiness.industrymedicine.diseaseScientific InvestigationsClinical neurologyrespiratory tract diseasesnervous system diseasesObstructive sleep apneamild obstructive sleep apneaDiabetes Mellitus Type 2NeurologyHypertensionNeurology (clinical)Human medicinebusiness030217 neurology & neurosurgery
researchProduct

European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring

2014

Given the increasing use of ambulatory blood pressure monitoring (ABPM) in both clinical practice and hypertension research, a group of scientists, participating in the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability, in year 2013 published a comprehensive position paper dealing with all aspects of the technique, based on the available scientific evidence for ABPM. The present work represents an updated schematic summary of the most important aspects related to the use of ABPM in daily practice, and is aimed at providing recommendations for proper use of this technique in a clinical setting by both specialists and practicing physici…

AdultMalemedicine.medical_specialtyAmbulatory blood pressureAdolescentPhysiologyMEDLINEPharmacyWhite coat hypertensionPractice PatternsBlood Pressure MonitoringMasked HypertensionAtrial FibrillationAmbulatoryInternal MedicinemedicineHumansambulatory blood pressure monitoring arterial hypertension clinic blood pressure measurement clinical indications guidelines home blood pressure measurement practice recommendationsObesityPractice Patterns Physicians'ChildIntensive care medicineReimbursementPhysicians'business.industryMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREBlood Pressure Monitoring Ambulatorymedicine.disease3. Good healthMasked HypertensionBlood pressureHypertensionPosition paperFemaleCardiology and Cardiovascular MedicinebusinessSoftwareWhite Coat HypertensionJournal of Hypertension
researchProduct

Prevenzione dell’ictus cerebrale nel diabete

2005

Diversi studi epidemiologici hanno chiaramente documentato che il diabete mellito costituisce un importante fattore di rischio ictus ischemico, mettendo altresì in evidenza la peggiore prognosi delle malattie cerebrovascolari nei pazienti diabetici. Tra le varietà di stroke ischemico quella lacunare sembra essere peculiare del paziente diabetico, essendo legata a una patologia delle piccole arterie penetranti dell’encefalo, nel contesto della tipica microangiopatia diabetica. L’ipertensione arteriosa costituisce il più importante fattore di rischio modificabile di ictus nel paziente diabetico ed è ampiamente dimostrato che la sua correzione farmacologica costituisce oggi la migliore possibi…

Arterial hypertensionStrokeDiabetes mellituPrevention
researchProduct

Potential of the EPA/DHA 6/1 formulation to prevent endothelial dysfunction and cardiopulmonary remodeling in pulmonary arterial hypertension in rats

2016

Pulmonary arterial hypertension (PAH) is characterized by remodeling of the small pulmonary arteries leading to a progressive increase in pulmonary vascular resistance and right ventricular failure. Pulmonary endothelial dysfunction, inflammation and oxidative stress promote the development of pulmonary hypertension. Omega-3 polyunsaturated fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acids (DHA) have been shown to protect the cardiovascular system and reduce inflammation and oxidative stress. The present study evaluate the potential of EPA:DHA 6:1 to prevent monocrotaline-induced PAH in rats. EPA:DHA 6:1 treatment (500 mg/kg/d, p.o) prevented the MCT-induced mean pul…

MonocrotalineAcide eicosapentaénoîque (EPA)Dysfonction endothélialeInflammation and oxidative stress[CHIM.THER] Chemical Sciences/Medicinal ChemistryDocosahexaenoic acids (DHA)Hypertension artérielle pulmonaireRemodelage pulmonairePulmonary arterial hypertensionAcide docosahexaénoïque (DHA)Remodelage du ventricule droitInflammation et stress oxydant[SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyCardiopulmonary remodelinglipids (amino acids peptides and proteins)Pulmonary endothelial dysfunctionEicosapentaenoic acid (EPA)
researchProduct

Knowledge gaps and future directions in cognitive functions in children and adolescents with primary arterial hypertension: A systematic review

2022

Arterial hypertension (AH) among adults is known to be associated with worse cognitive outcomes. Similarly, children and adolescents with AH could be expected to underperform during neuropsychological evaluations when compared with healthy peers. Our aims were to review the existing literature on cognitive functioning among children and adolescents with primary AH and to identify what additional evidence may be needed to substantiate the impact of hypertension on poor cognitive outcomes in this population. We conducted a systematic review of articles in PubMed and Web of Science published before 17 January 2022, reporting on cognitive testing among children and adolescents with primary AH. …

Funcions executives (Neuropsicologia)JovesPressió sanguíniaNeuropsicologia pediàtricaChildhoodAdolescènciaAdolescencePediatric neuropsychologyBlood pressureblood pressure ; primary arterial hypertension ; executive functions ; neuropsychology ; pediatrics ; childhood ; adolescence ; HyperChildNETExecutive functions (Neuropsychology)Cardiology and Cardiovascular MedicineInfantsInfància
researchProduct

Behaviour of carbonyl groups in several clinical conditions: Analysis of our survey

2019

Protein carbonylation is a marker of oxidative protein damage, that is likely involved in the pathogenesis of several diseases. The aim of this study was to evaluate the protein carbonyl (PC) groups in different clinical conditions. It included different groups of subjects: 81 trained subjects; 23 subjects with mild essential hypertension; 31 middle-aged subjects with metabolic syndrome (MS); 106 subjects with MS not selected for age (subdivided into two subgroups, with and without diabetes mellitus); 91 obese adults subdivided in two subgroups (BMI 30-35 Kg/m2 and BMI &gt; 35 kg/m2); 48 subjects with obstructive sleep apnea syndrome (OSAS) subdivided in accordance with the apnea/hypopnea i…

AdultMalemedicine.medical_specialtyOxidative stress arterial hypertension metabolic syndrome juvenile myocardial infarction chronic kidney failurePhysiologymedicine.medical_treatment030204 cardiovascular system & hematologyEssential hypertension030218 nuclear medicine & medical imagingProtein Carbonylation03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesPhysiology (medical)Internal medicineDiabetes mellitusmedicineHumansDiseaseMyocardial infarctionDialysisbusiness.industryHematologymedicine.diseaseObstructive sleep apneaFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessOxidation-ReductionHypopneaBiomarkersKidney diseaseClinical Hemorheology and Microcirculation
researchProduct